0

Fluvoxamine Maleate

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP61718829-A
CAS61718-82-9
Structure
MDL NumberMFCD00269809
Molecular Weight434.41
InChI KeyLFMYNZPAVPMEGP-PIDGMYBPSA-N; traceable to PhEur Y0000854; traceable to USP 1285909
DescriptionPharmaceutical Secondary Standard; Certified Reference Material
Gradecertified reference material; pharmaceutical secondary standard
Size500MG
1

Anti-parkinsonian Effects of Fluvoxamine Maleate in Maternally Separated Rats

Ernest Dallé, Willie M U Daniels, Musa V Mabandla

Int J Dev Neurosci. 2016 Oct;53:26-34.

PMID: 27338206

1

Early Life Stress, Depression And Parkinson's Disease: A New Approach

Ernest Dallé, Musa V Mabandla

Mol Brain. 2018 Mar 19;11(1):18.

PMID: 29551090

1

Fluvoxamine Maleate in the Treatment of Depression: A Single-Center, Double-Blind, Placebo-Controlled Comparison With Imipramine in Outpatients

J L Claghorn, C Q Earl, D D Walczak, K A Stoner, L F Wong, D Kanter, V P Houser

J Clin Psychopharmacol. 1996 Apr;16(2):113-20.

PMID: 8690826

1

Fluvoxamine Maleate Normalizes Striatal Neuronal Inflammatory Cytokine Activity in a Parkinsonian Rat Model Associated With Depression

Ernest Dallé, Willie M U Daniels, Musa V Mabandla

Behav Brain Res. 2017 Jan 1;316:189-196.

PMID: 27569183

1

Gateways to Clinical Trials. June 2002

M Bayes, X Rabasseda, J R Prous

Methods Find Exp Clin Pharmacol. 2002 Jun;24(5):291-327.

PMID: 12168506

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode